English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Nightmare Disorder, Psychopathology Levels, and Coping in a Diverse Psychiatric Sample

MPS-Authors
/persons/resource/persons80538

Spoormaker,  Victor
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

van Schagen, A., Lancee, J., Swart, M., Spoormaker, V., & van den Bout, J. (2017). Nightmare Disorder, Psychopathology Levels, and Coping in a Diverse Psychiatric Sample. JOURNAL OF CLINICAL PSYCHOLOGY, 73(1), 65-75. doi:10.1002/jclp.22315.


Cite as: https://hdl.handle.net/21.11116/0000-0001-9C50-5
Abstract
Objective: Nightmares are associated with psychopathology and impaired coping in the general population. However, little is known about this association in a psychiatric population. In this study, we investigate whether patients with diverse psychiatric disorders have increased symptomatology and different coping styles if they suffer from comorbid nightmare disorder. Method: Participants were 498 patients with diverse moderate to severe psychiatric disorders. As part of a standard assessment procedure, they filled out questionnaires regarding nightmares, psychopathology, personality pathology, and coping. Results: A multivariate analysis of covariance and post hoc tests showed that patients with nightmare disorder scored higher on psychopathology (eta(2)(p) = .03; p = .001) and personality pathology (eta(2)(p) = .01-.03; p < .05). No significant differences were found with regards to coping strategies. Conclusion: Nightmare disorder is associated with higher levels of psychopathology and personality pathology in a sample of patients with diverse psychiatric disorders. (C) 2016 Wiley Periodicals, Inc.